You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia, Monocytic, Acute

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • CD123 targeted CAR-NK cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Aug 28, 2023

AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

Not yet recruiting
  • AML
  • +11 more
  • (no location specified)
Aug 14, 2023

H19 in Acute Lymphoblastic Leukemia.

Not yet recruiting
  • Acute Lymphoid Leukemia
    • (no location specified)
    Jul 11, 2023

    Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

    Not yet recruiting
    • Breast Cancer
    • +9 more
    • Assessment tool IA3-CP with SDoH
    • Assessment tool IA3-CP without SDoH
    • (no location specified)
    May 22, 2023

    Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

    Recruiting
    • Acute Myeloid Leukemia
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jun 23, 2023

    Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

    Active, not recruiting
    • Relapsed Adult ALL
    • Relapsed Adult AML
    • Changchun, Jilin, China
      First Hospital of Jilin University
    Nov 19, 2023

    Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Lyon, France
      Centre Léon Bérard
    Nov 30, 2023

    Acute Myeloid Leukemia Trial (ABBV-787)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • (no location specified)
    Sep 29, 2023

    Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid

    Recruiting
    • Acute Lymphoblastic Leukemia in Remission
    • +11 more
    • Astatine At 211 Anti-CD45 Monoclonal Antibody BC8-B10
    • +8 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 24, 2022

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • (no location specified)
    May 29, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission Trial in São Paulo (Bortezomib)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • Acute Lymphoblastic Leukemia With Failed Remission
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de Sao Paulo
    Sep 12, 2023

    Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Mitoxantrone hydrochloride liposome injection
    • +3 more
    • Tianjin, China
      Institute of Hematology & Blood Diseases Hospital
    Jul 1, 2023

    ALL, Adult, AML, Adult Trial (BN104)

    Not yet recruiting
    • ALL, Adult
    • AML, Adult
    • (no location specified)
    Sep 19, 2023

    B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

    Recruiting
    • B-Cell Lymphoblastic Leukemia
    • Acute Lymphoblastic Leukemia
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2023

    Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Oral azacitidine
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

    Not yet recruiting
    • Acute Myeloid Leukemia
    • Beijing, Beijing, China
      Yuan Kong
    Sep 4, 2023

    B-Cell Non Hodgkin Lymphoma, B-Cell Acute Lymphoblastic Leukemia Trial in Hanoi (anti-CD19 CAR T-cells)

    Recruiting
    • B-Cell Non Hodgkin Lymphoma
    • B-Cell Acute Lymphoblastic Leukemia
    • anti-CD19 CAR T-cells
    • Hanoi, Vietnam
      Vinmec Research Institute of Stem Cell and Gene Technology
    Sep 5, 2023

    Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

    Not yet recruiting
    • Chemotherapy-Induced Thrombocytopenia
    • Hetrombopag Olamine
    • (no location specified)
    Jul 5, 2023

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • (no location specified)
    Nov 9, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • HY004
    • +2 more
    • (no location specified)
    Aug 18, 2023

    Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia

    Recruiting
    • Acute Leukemia
    • No intervention, observation study
    • Hangzhou, Zhejiang, China
      Clinical research ethics committee of the first affiliated hospi
    Oct 6, 2023

    B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • QH103 Cell Injection
    • +2 more
    • Hefei, Anhui, China
      Anhui Provincial Hospital
    Sep 21, 2023

    Lymphoblastic Leukemia Trial in Palo Alto (Dasatinib)

    Not yet recruiting
    • Lymphoblastic Leukemia
    • Palo Alto, California
      Stanford University
    Aug 14, 2023

    Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      Sep 22, 2023

      Study of miRNA-155 in Acute Leukemia

      Not yet recruiting
      • Acute Leukemia
      • BM aspirate
      • (no location specified)
      Mar 30, 2023